This inventor holds 1 USPTO granted patent. Top assignees: Leland Stanford Junior University, University Health Network. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,509 
1 out of 311 
Years Active: 2010
Title: Carole Galligan: Innovator in Rheumatoid Arthritis and Osteoarthritis Treatment
Introduction
Carole Galligan is a notable inventor based in Scarborough, Canada. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of rheumatoid arthritis and osteoarthritis. Her innovative work has the potential to improve the lives of many individuals suffering from these debilitating conditions.
Latest Patents
Carole Galligan holds a patent for her invention titled "Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis." This invention introduces a novel cell that serves as a precursor to a fibroblast-like synovial cell. The novel cell is identified as a circulating synovial tissue cell that tests positive for collagen, CD34, CD45, prolyl 4-hydroxylase, and CD14. Additionally, her invention encompasses methods for diagnosing or monitoring rheumatoid arthritis and/or osteoarthritis through gene expression profiles, protein expression profiles, and protein phosphorylation profiles of various cell types, including the novel precursor, CD3+ cells, synovial tissue fibroblast-like synovial cells, and fibrocytes. Furthermore, the invention includes methods to identify substances that can treat or prevent rheumatoid arthritis and/or osteoarthritis.
Career Highlights
Throughout her career, Carole Galligan has worked with esteemed institutions such as the University Health Network and Leland Stanford Junior University. Her research has been pivotal in advancing the understanding of rheumatoid arthritis and osteoarthritis, leading to innovative diagnostic and treatment methods.
Collaborations
Carole has collaborated with notable colleagues, including Eleanor Fish and Kathy Siminovitch. These partnerships have contributed to her success and the impact of her research in the medical community.
Conclusion
Carole Galligan's contributions to the field of medical research, particularly in the treatment of rheumatoid arthritis and osteoarthritis, highlight her innovative spirit and dedication to improving patient outcomes. Her patented methods and collaborative efforts continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile